Work

Single-step nanoparticle antigen presentation system for tumor immunotherapy

Year: 2015

Type: conference-abstract

Abstract: Meeting abstracts While only 10-30% of patients treated with currently approved single immunotherapies demonstrate long-term benefit, treatment efficacy in responders correlates with increased CD8+ T cell responses to neoantigens (tumor antigens hidden from the immune system). Thus, to improve

Source: Journal for ImmunoTherapy of Cancer

DOI: 10.1186/2051-1426-3-s2-p319

Authors: Frederick Kohlhapp, Erica Huelsmann, Jai Rudra, Arman Nabatiyan, Andrew Zloza

Institutions: Rutgers, The State University of New Jersey, Rush University, The University of Texas Medical Branch at Galveston

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,490

OpenAlex ID: W2222795403

Cites:

Cited by: 2

Related to: 10